Results 111 to 120 of about 67,068 (268)

Status of Homocysteine in Polycystic Ovary Syndrome (PCOS)

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2014
Polycystic ovary syndrome (PCOS) is the most common endocrine disease in women of reproductive age and is estimated to affect 5-10 % of the population. Women with PCOS have a clustering of cardiovascular risk factors, such as obesity, dyslipidemia, impaired glucose tolerance and hypertension.
Priyanka Maleedhu, Vijayabhaskar M., Sharma S.S.B., Praveen K Kodumuri, Vasundhara Devi D.   +4 more
openaire   +3 more sources

Dietary Strategies and Nutritional Management in Patients Receiving GLP‐1 and Dual GIP/GLP‐1 Receptor Agonists as Adjuncts to Lifestyle Interventions: A Systematic Review of Randomised Clinical Trials

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and dual GIP/GLP‐1 RAs are widely used to manage obesity, prediabetes and type 2 diabetes, typically in combination with lifestyle interventions. Their nutritional implications, however, remain unclear.
Rayanne Santos de Paulo, Dandara Baia Bonifácio, Matheus Henrique Lana de Carvalho, Josefina Bressan   +3 more
wiley   +1 more source

The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy

International Journal of Endocrinology, 2018
Polycystic ovary syndrome is a highly frequent reproductive-endocrine disorder affecting up to 8–10% of women worldwide at reproductive age. Although its etiology is not fully understood, evidence suggests that insulin resistance, with or without ...
Eduardo Spinedi, Daniel P. Cardinali
doaj   +1 more source

A guide to understanding polycystic ovary syndrome (PCOS) [PDF]

Journal of Family Planning and Reproductive Health Care, 2014
Polycystic ovary syndrome (PCOS) is the commonest endocrine disorder affecting women of reproductive age. Some 20% of women will have polycystic ovaries on an ultrasound scan and around 7% of women have the additional clinical or biochemical features of PCOS. As a complex multisystem disorder its background can be confusing to understand.
openaire   +2 more sources

Obesity and polycystic ovary syndrome : implications for pathogenesis and novel management strategies [PDF]

, 2019
Polycystic ovary syndrome (PCOS) is a common female condition typified by reproductive, hyperandrogenic, and metabolic features. Polycystic ovary syndrome is a genetic condition, exacerbated by obesity.
Barber, Thomas M., Franks, Stephen, Hanson, Petra, Weickert, Martin O.   +3 more
core   +2 more sources

The Experiences of Women With Polycystic Ovary Syndrome of the Healthcare They Receive: A Qualitative Systematic Review

Journal of Advanced Nursing, EarlyView.
ABSTRACT Background More than 12% of women worldwide are affected by polycystic ovary syndrome (PCOS), whose symptoms are similar to those of puberty, often leading to delayed diagnosis and missing the opportunity for early intervention. This not only puts PCOS women under physical and mental stress but also reduces their trust in doctors and makes ...
Baoying Zhang, Joan Lalor
wiley   +1 more source

Perceived Effects and Prevention of Polycystic Ovary Syndrome among Women Living in Ilorin-South LGA, Kwara State, Nigeria

Pan-African Journal of Health and Environmental Science
Background: Women of reproductive age are susceptible to polycystic ovarian syndrome (PCOS), one of the most prevalent hormonal disorders. The disease begins at puberty and symptoms could fluctuate over time. This condition is characterized by disruption
Abdulqudus Tosin Jamiu, Kamalud-deen Adekunle Uthman, Tawakalitu Kikelomo Ijaodola, Khadijah Morenikeji Mutairu, Opeyemi Funke Obaditan   +4 more
doaj   +1 more source

Update of the EuroGuiDerm evidence‐based guideline for the treatment of acne—Short version

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The 2025 EuroGuiDerm guideline update provides evidence‐based recommendations for acne management, addressing systemic antibiotics, systemic isotretinoin, hormonal therapies including spironolactone and contraceptives, and new topical agents. Key considerations include treatment duration, safety, pregnancy‐specific guidance and minimizing antibiotic ...
Alexander Nast, Bassel H. Al Wattar, Marie Beylot Barry, Holger Brüggemann, Zrinka Bukvić Mokos, Dawn M. Caruana, Klaus Degitz, Clio Dessinioti, Brigitte Dréno, Rieke J. B. Driessen, Harald Gollnick, Merete Hædersdal, Alexander Katoulis, Severin Läuchli, Julien Lambert, Alison M. Layton, Giuseppe Micali, Falk R. Ochsendorf, Thozhukat Sathyapalan, Katarina Zak Stangeland, Simon Francis Thomsen, Daniel Töröcsik, Antonia Pennitz   +22 more
wiley   +1 more source

Polycystic Ovary Syndrome - treatment update

Quality in Sport
Introduction: Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders. It gets its name from the characteristic appearance of the ovaries observed in ultrasound imaging.
Marta Szymura, Marek Jarosław Molenda, Oliwia Brygida Woszczyńska, Paweł Maciej Rycąbel, Mateusz Romaniuk, Maria Wachowska, Mateusz Paniak, Agnieszka Ewelina Wojciechowska, Michał Brunon Krawczyk, Wojciech Jan Sowiński   +9 more
doaj   +1 more source

Polycystic Ovary Syndrome - diagnosis and treatment [PDF]

, 2015
: Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder, and a major cause of infertility in women. An excessive amount of androgen hormones are produced by polycystic ovaries in PCOS with irregular menstruation and anovulation as
Hussain, Amna
core